Kintara Therapeutics, Inc (KTRA) PT Raised to $7 at Aegis Capital
Tweet
Share
E-mailGet Alerts KTRA Hot Sheet
Price: $1.36 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 67
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 16 | New: 67
Trade Now!
Join SI Premium – FREE
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Aegis Capital analyst Nathan Weinstein raised the price target on Kintara Therapeutics, Inc (NASDAQ: KTRA) to $7.00 (from $6.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Osisko Gold Royalties Ltd. (OR:CN) (OR) PT Raised to Cdn$23 at Stifel Canada
- Fiore Gold Ltd (F:CN) (FIOGF) PT Lowered to Cdn$2.30 at Stifel Canada
- B.Riley Assumes Colony Northstar Credit Real Estate (CLNC) at Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
